María D.
Odero
Investigadora hasta 2024
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2020
-
A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia
Blood Cancer Journal, Vol. 10, Núm. 1
-
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
Cancer Letters, Vol. 468, pp. 1-13
-
Data mining analysis of the PP2A cell cycle axis in mesothelioma patients
Journal of Cellular Physiology, Vol. 235, Núm. 6, pp. 5284-5292